Primary hyperaldosteronism differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
(6 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | [[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Primary_hyperaldosteronism]] | ||
{{CMG}}; {{AE}} {{HK}} | |||
==Overview== | ==Overview== | ||
Primary hyperaldosteronism must be differentiated from other diseases that cause [[hypertension]] and [[hypokalemia]] such as [[renal artery stenosis]], [[cushing's syndrome]], [[congenital adrenal hyperplasia]], [[Liddle's syndrome]], [[diuretic]] use, [[licorice]] ingestion and [[renin-secreting tumors]]. | Primary hyperaldosteronism must be differentiated from other diseases that cause [[hypertension]] and [[hypokalemia]], such as [[renal artery stenosis]], [[cushing's syndrome]], [[congenital adrenal hyperplasia]], [[Liddle's syndrome]], [[diuretic]] use, [[licorice]] ingestion, and [[renin-secreting tumors]]. | ||
==Differentiating Primary Hyperaldosteronism from other Diseases== | ==Differentiating Primary Hyperaldosteronism from other Diseases== | ||
Line 16: | Line 17: | ||
*[[Licorice]] ingestion | *[[Licorice]] ingestion | ||
*[[Renin]]-secreting [[Tumor|tumors]] | *[[Renin]]-secreting [[Tumor|tumors]] | ||
{{familytree/start}}{{familytree | | | | | | | | | A01 | | | | | |A01=Hypertension and Hypokalemia}} | {{familytree/start}}{{familytree | | | | | | | | | A01 | | | | | |A01=[[Hypertension]] and [[Hypokalemia]]}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | | | | | | | B01 | | | | | |B01=Plasma renin activity}} | {{familytree | | | | | | | | | B01 | | | | | |B01=[[Plasma renin activity]]}} | ||
{{familytree | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }} | {{familytree | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }} | ||
{{familytree | | C01 | | | | | | | | | | | |C02|C01=Normal or High (Plasma Renin/Aldosterone ratio <10|C02=Suppressed (Plasma Renin/Aldosterone ratio >20}} | {{familytree | | C01 | | | | | | | | | | | |C02|C01=Normal or High (Plasma [[Renin]]/[[Aldosterone]] ratio <10)|C02=Suppressed (Plasma [[Renin]]/[[Aldosterone]] ratio > 20)}} | ||
{{familytree | | |!| | | | | | | | | | | | | |!| }} | {{familytree | | |!| | | | | | | | | | | | | |!| }} | ||
{{familytree | | D01 | | | | | | | | | | | |D02|D01= | {{familytree | | D01 | | | | | | | | | | | |D02|D01=• [[Renin-secreting tumors]]<br>• [[Diuretic]] use<br>• [[Renovascular hypertension]]<br>• [[Coarctation of aorta]]<br>• [[Malignant hypertension]]|D02=Urinary [[aldosterone]]}} | ||
{{familytree | | | | | | | | | | | | |,|-|-|-|+|-|-|-|-|.|}} | {{familytree | | | | | | | | | | | | |,|-|-|-|+|-|-|-|-|.|}} | ||
{{familytree | | | | | | | | | | | | E01 | | E02 | | | E03 |E01=Elevated|E02=Normal|E03=Low|}} | {{familytree | | | | | | | | | | | | E01 | | E02 | | | E03 |E01=Elevated|E02=Normal|E03=Low|}} | ||
{{familytree | | | | | | | | | | | | |!| | | |!| | | | |!| | }} | {{familytree | | | | | | | | | | | | |!| | | |!| | | | |!| | }} | ||
{{familytree | | | | | | | | | | | | F01 | | F02 | | | F03 |F01=Conn's syndrome (Primary aldosteronism)|F02=Profound K | {{familytree | | | | | | | | | | | | F01 | | F02 | | | F03 |F01=Conn's syndrome (Primary aldosteronism)|F02=Profound [[sodium|K]] depletion|F03=• [[17 alpha hydroxylase deficiency]]<br>• [[11 beta hydroxylase deficiency]]<br>• [[Liddle's syndrome]]<br>• [[Licorice]] ingestion<br>• Deoxycortisone producing tumor|}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | |!| | | | }} | {{familytree | | | | | | | | | | | | | | | | | | | | | |!| | | | }} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | |G01|G01=Add Mineralocrticoid antagonist for 8 weeks}} | {{familytree | | | | | | | | | | | | | | | | | | | | |G01|G01=Add Mineralocrticoid antagonist for 8 weeks}} | ||
{{familytree | | | | | | |,|-|-|-|-|-|-|-|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|-|-|-|-|-|-|-|.}} | {{familytree | | | | | | |,|-|-|-|-|-|-|-|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|-|-|-|-|-|-|-|.}} | ||
{{familytree | | | | | |H01| | | | | | | | | | | | | | | | | | | | | | | | | | | |H02|H01=BP response|H02=No BP response}} | {{familytree | | | | | |H01| | | | | | | | | | | | | | | | | | | | | | | | | | | |H02|H01=[[blood pressure|BP]] response|H02=No [[blood pressure|BP]] response}} | ||
{{familytree | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |!| }} | {{familytree | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |!| }} | ||
{{familytree | | | | | |I01| | | | | | | | | | | | | | | | | | | | | | | | | | | |I02|I01=• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency)<br>• Licorice ingestion<br> | {{familytree | | | | | |I01| | | | | | | | | | | | | | | | | | | | | | | | | | | |I02|I01=• [[Deoxycorticosterone]] excess ([[Tumor]], [[17 alpha hydroxylase deficiency|17 alpha hydroxylase]], and [[11 beta hydroxylase deficiency]])<br>• [[Licorice]] ingestion<br>• [[Glucocorticoid]] resistance|I02=[[Liddle's syndrome]]|}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 39: | Line 40: | ||
|+ | |+ | ||
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Differential Diagnoses}} | ! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Differential Diagnoses}} | ||
! colspan=" | ! colspan="9" align="center" style="background:#4479BA; color: #FFFFFF; width: 400px;" + | Clinical features | ||
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|History Findings}} | ! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|History Findings}} | ||
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Laboratory Findings}} | ! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Laboratory Findings}} | ||
Line 51: | Line 51: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fatigue | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fatigue | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Constipation | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Constipation | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Pruritis | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Pruritis | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ambiguous genitalia | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ambiguous genitalia | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Renin-Secreting tumors]] | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Renin-secreting tumors|Renin-Secreting tumors]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | ✔ | | style="padding: 5px 5px; background: #F5F5F5;" | ✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | ||
Line 70: | Line 66: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Drug-resistant hypertension | * Drug-resistant [[hypertension]] | ||
* Chronic headaches | * Chronic [[Headache|headaches]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Normal [[renal function tests]] | * Normal [[renal function tests]] | ||
Line 87: | Line 83: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | - | | style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | ||
Line 94: | Line 88: | ||
*Young patients ([[neonates]]) may have history of: | *Young patients ([[neonates]]) may have history of: | ||
** [[Failure to thrive]] | ** [[Failure to thrive]] | ||
** Poor feeding | ** [[Poor feeding]] | ||
** Lethargy | ** [[Lethargy]] | ||
** [[Turner syndrome|Turner's syndrome]] | ** [[Turner syndrome|Turner's syndrome]] | ||
** Familial predisposition | ** Familial predisposition | ||
Line 116: | Line 110: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | - | | style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | - | | style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" | - | | style="padding: 5px 5px; background: #F5F5F5;" | - | ||
Line 131: | Line 123: | ||
* Hypokalemia | * Hypokalemia | ||
* Increased 11-DOC levels | * Increased 11-DOC levels | ||
* Increased androgens | * Increased [[androgens]] | ||
* Low [[urinary]] [[aldosterone]] level | * Low [[urinary]] [[aldosterone]] level | ||
|- | |- | ||
Line 141: | Line 133: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | - | | style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" | - | | style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" | - | | style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" | - | | style="padding: 5px 5px; background: #F5F5F5;" | - | ||
Line 156: | Line 146: | ||
* Low [[urinary]] [[aldosterone]] level | * Low [[urinary]] [[aldosterone]] level | ||
|- | |- | ||
|'''[[Uremia]]''' | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''[[Uremia]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" |✔ | ||
Line 164: | Line 154: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 178: | Line 166: | ||
** Delayed [[Deep tendon reflex|deep tendon reflexes]] | ** Delayed [[Deep tendon reflex|deep tendon reflexes]] | ||
** [[Muscle wasting]] | ** [[Muscle wasting]] | ||
* [[Encephalopathy]] | ** [[Encephalopathy]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Increased [[blood urea nitrogen]] ([[Blood urea nitrogen|BUN]]) and [[creatinine]] ([[Cr]]) | * Increased [[blood urea nitrogen]] ([[Blood urea nitrogen|BUN]]) and [[creatinine]] ([[Cr]]) | ||
Line 184: | Line 172: | ||
* Decreased [[serum]] [[Vitamin D3|vitamin 1,25 dihydroxy vitamin D3]] level | * Decreased [[serum]] [[Vitamin D3|vitamin 1,25 dihydroxy vitamin D3]] level | ||
|- | |- | ||
|[[Liddle's syndrome|'''Liddle's syndrome''']] | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Liddle's syndrome|'''Liddle's syndrome''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" |✔ | ||
Line 192: | Line 180: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" |✔ | | style="padding: 5px 5px; background: #F5F5F5;" |✔ | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Family history]] of Liddle's syndrome ([[autosomal dominant inheritance]]) | * [[Family history]] of [[Liddle's syndrome]] ([[autosomal dominant inheritance]]) | ||
* [[Nephropathy]] | * [[Nephropathy]] | ||
* [[Arrythmias]] | * [[Arrythmias]] |
Latest revision as of 19:31, 25 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Primary hyperaldosteronism must be differentiated from other diseases that cause hypertension and hypokalemia, such as renal artery stenosis, cushing's syndrome, congenital adrenal hyperplasia, Liddle's syndrome, diuretic use, licorice ingestion, and renin-secreting tumors.
Differentiating Primary Hyperaldosteronism from other Diseases
Primary hyperaldosteronism (PA) should be differentiated from other diseases causing hypertension and hypokalemia for example:[1][1][2][3][4][5][6][7][8][9][10][11][12][13][14][15]
- Renal artery stenosis
- Cushing's syndrome
- Congenital adrenal hyperplasia (CAH)
- Liddle's syndrome
- Diuretic use
- Licorice ingestion
- Renin-secreting tumors
Hypertension and Hypokalemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Plasma renin activity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal or High (Plasma Renin/Aldosterone ratio <10) | Suppressed (Plasma Renin/Aldosterone ratio > 20) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• Renin-secreting tumors • Diuretic use • Renovascular hypertension • Coarctation of aorta • Malignant hypertension | Urinary aldosterone | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Elevated | Normal | Low | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conn's syndrome (Primary aldosteronism) | Profound K depletion | • 17 alpha hydroxylase deficiency • 11 beta hydroxylase deficiency • Liddle's syndrome • Licorice ingestion • Deoxycortisone producing tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Add Mineralocrticoid antagonist for 8 weeks | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BP response | No BP response | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• Deoxycorticosterone excess (Tumor, 17 alpha hydroxylase, and 11 beta hydroxylase deficiency) • Licorice ingestion • Glucocorticoid resistance | Liddle's syndrome | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential Diagnoses | Clinical features | History Findings | Laboratory Findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Headache and hypertension | Nausea and vomiting | Palpitations | Shortness of breath | Diminished pulses | Fatigue | Constipation | Pruritis | Ambiguous genitalia | |||
Renin-Secreting tumors | ✔ | ✔ | ✔ | ✔ | - | - | - | - | - |
|
|
Coarctation of aorta | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | - | - | - |
|
|
11-beta hydroxylase deficiency | ✔ (Hypertensive crisis due to increased 11-deoxycorticosterone-11-DOC) | ✔ | ✔ | - | - | ✔ | - | - | ✔ |
|
|
17-alpha hydroxylase deficiency | ✔ | ✔ | ✔ | - | - | - | - | - | ✔ |
|
|
Uremia | ✔ | ✔ | ✔ | - | ✔ | ✔ | ✔ | - |
|
| |
Liddle's syndrome | ✔ | ✔ | ✔ | - | - | - | ✔ | - | - |
|
References
- ↑ 1.0 1.1 Wada N, Jin S, Hui SP, Yanagisawa K, Kurosawa T, Chiba H (2014). "[Differential diagnosis of primary aldosteronism by measurement of hybrid steroids using mass spectrometry]". Rinsho Byori (in Japanese). 62 (3): 276–82. PMID 24800505.
- ↑ Nielsen ML, Pareek M, Andersen I (2012). "[Liquorice-induced hypertension and hypokalaemia]". Ugeskr. Laeg. (in Danish). 174 (15): 1024–5. PMID 22487411.
- ↑ Chow KM, Ma RC, Szeto CC, Li PK (2012). "Polycystic kidney disease presenting with hypertension and hypokalemia". Am. J. Kidney Dis. 59 (2): 270–2. doi:10.1053/j.ajkd.2011.08.020. PMID 21962616.
- ↑ Sarafidis PA, Georgianos PI, Germanidis G, Giavroglou C, Nikolaidis P, Lasaridis AN, Madias NE (2012). "Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis". Am. J. Kidney Dis. 59 (3): 434–8. doi:10.1053/j.ajkd.2011.11.001. PMID 22154539.
- ↑ Khosla N, Hogan D (2006). "Mineralocorticoid hypertension and hypokalemia". Semin. Nephrol. 26 (6): 434–40. doi:10.1016/j.semnephrol.2006.10.004. PMID 17275580.
- ↑ Weiner ID (2013). "Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism". Semin. Nephrol. 33 (3): 265–76. doi:10.1016/j.semnephrol.2013.04.007. PMC 3748390. PMID 23953804.
- ↑ Martell-Claros N, Abad-Cardiel M, Alvarez-Alvarez B, García-Donaire JA, Pérez CF (2015). "Primary aldosteronism and its various clinical scenarios". J. Hypertens. 33 (6): 1226–32. doi:10.1097/HJH.0000000000000546. PMID 25715092.
- ↑ Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB (2000). "Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program". Hypertension. 35 (5): 1025–30. PMID 10818057.
- ↑ Rossi E, Farnetti E, Nicoli D, Sazzini M, Perazzoli F, Regolisti G, Grasselli C, Santi R, Negro A, Mazzeo V, Mantero F, Luiselli D, Casali B (2011). "A clinical phenotype mimicking essential hypertension in a newly discovered family with Liddle's syndrome". Am. J. Hypertens. 24 (8): 930–5. doi:10.1038/ajh.2011.76. PMID 21525970.
- ↑ Ruecker B, Lang-Muritano M, Spanaus K, Welzel M, l'Allemand D, Phan-Hug F, Katschnig C, Konrad D, Holterhus PM, Schoenle EJ (2015). "The Aldosterone/Renin Ratio as a Diagnostic Tool for the Diagnosis of Primary Hypoaldosteronism in Newborns and Infants". Horm Res Paediatr. 84 (1): 43–8. doi:10.1159/000381852. PMID 25968592.
- ↑ Ardhanari S, Kannuswamy R, Chaudhary K, Lockette W, Whaley-Connell A (2015). "Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension". Adv Chronic Kidney Dis. 22 (3): 185–95. doi:10.1053/j.ackd.2015.03.002. PMID 25908467.
- ↑ Iglesias P, Tajada P, Martínez I, Díez JJ (2009). "[Salt-wasting congenital adrenal hyperplasia associated to hyperreninemic hyperaldosteronism]". Med Clin (Barc) (in Spanish; Castilian). 132 (2): 80–1. doi:10.1016/j.medcli.2008.09.002. PMID 19174076.
- ↑ Kikuta Y, Sanjo K, Nakajima K, Ashizawa I, Ojima M (1988). "Primary aldosteronism in childhood due to primary adrenal hyperplasia". Tohoku J. Exp. Med. 155 (1): 57–70. PMID 3413779.
- ↑ Hassan-Smith Z, Stewart PM (2011). "Inherited forms of mineralocorticoid hypertension". Curr Opin Endocrinol Diabetes Obes. 18 (3): 177–85. doi:10.1097/MED.0b013e3283469444. PMID 21494136.
- ↑ Bartter FC, Henkin RI, Bryan GT (1968). "Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia". J. Clin. Invest. 47 (8): 1742–52. doi:10.1172/JCI105864. PMC 297334. PMID 4299011.